Man found guilty on 12 counts for running illegal biolab in Reedley – Image for illustrative purposes only (Image credits: Pixabay)
Reedley, Calif. – A federal jury in Sacramento has convicted the operator of an illegal biological laboratory discovered in Reedley more than three years ago. The verdict came after a two-week trial and addressed charges tied to the sale of faulty COVID-19 test kits across the country. The outcome closes a significant chapter in a case that drew national attention to biosafety concerns in the Central Valley.
Details of the Conviction
The jury found Jia Bei Zhu, also known as David He, guilty on every count presented by prosecutors. The 64-year-old Chinese national and former Clovis resident now faces sentencing in August. He could receive more than 20 years in prison if the maximum penalties apply. Prosecutors outlined a scheme that involved the distribution of more than one million defective test kits. The charges included one count of conspiracy to commit wire fraud, eight counts of substantive wire fraud, two counts of distributing adulterated and misbranded medical devices, and one count of making a false statement to the Food and Drug Administration. The trial focused on evidence that Zhu misrepresented his identity and the quality of the products sold to customers nationwide.
Connection to the Reedley Site
The conviction stems from an investigation that began when local officials discovered the makeshift laboratory inside a Reedley warehouse in 2023. Authorities described the facility as an unauthorized operation containing biological materials and equipment that raised immediate safety alarms. Federal agents later linked the site directly to Zhu’s business activities. The Reedley location had operated without proper permits or oversight, prompting concerns from health officials about potential hazards. Investigators determined that the lab supported the production and distribution of the medical devices at the center of the fraud case. The discovery led to broader scrutiny of how such facilities could operate undetected for an extended period.
Public Health and Regulatory Concerns
The case highlights ongoing challenges in regulating medical devices during and after the pandemic. Faulty test kits distributed through the scheme could have misled users about their health status, creating risks for individuals and communities. Federal authorities emphasized that the misbranded products violated strict standards designed to protect consumers. The verdict also underscores the role of the FDA in pursuing false statements from manufacturers. Zhu’s conviction on that specific count reflects the agency’s determination to hold individuals accountable for misleading regulators about product origins and quality. Local leaders in Fresno County have previously described similar operations as potential threats to regional security and public safety.
Next Steps in the Case
Zhu’s sentencing hearing is scheduled for August, where the court will consider the full scope of the fraud and its impact. Prosecutors have indicated they will seek a substantial prison term based on the volume of defective tests sold and the deliberate nature of the misrepresentations. The outcome may influence future enforcement actions against similar unauthorized laboratories. The Reedley investigation continues to serve as a reference point for officials examining biosafety gaps. While the immediate threat from the site has been addressed, the conviction reinforces the need for vigilance in monitoring facilities that handle biological materials.
